S K Sah1, S K Sahu2, B Lamichhane1, G K Bhatta3, K B Bhandari4, P Owiti5, S S Majumdar6. 1. National Tuberculosis Centre, Thimi, Bhaktapur, Nepal. 2. Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India. 3. South Asian Association for Regional Cooperation Tuberculosis and HIV/AIDS Centre, Thimi, Bhaktapur, Nepal. 4. National Centre for AIDS and STD Control, Kathmandu, Nepal. 5. Academic Model Providing Access to Healthcare Partnership, Eldoret, Kenya. 6. Centre for International Health, Burnet Institute, Melbourne, Victoria, Australia.
Abstract
Setting: The three government tertiary care hospitals providing care for people living with the human immunodeficiency virus (PLHIV) in Kathmandu, Nepal. Objectives: To assess 1) the screening cascades for intensified case finding for tuberculosis (TB), 2) isoniazid preventive therapy (IPT), including demographic and clinical factors associated with treatment interruption, and 3) TB infection control (IC) in the health facilities. Design: A cross-sectional study of new PLHIV enrolled from January 2012 to December 2014. Results: Among 572 registered PLHIV, 91% were on antiretroviral therapy. Of those registered, 561 (98%) were screened for TB and 73 (13%) were diagnosed with TB (17 [25%] sputum smear-positive, 17 [25%] smear-negative and 35 [51%] extra-pulmonary). Among the 488 (87%) PLHIV without active TB, 157 (32%) were initiated on IPT, of whom 136 (87%) completed treatment and 17 (11%) interrupted treatment. Those who experienced adverse events were 12 times more likely to interrupt IPT. TB IC showed gaps in personal control measures and supporting structures and policies. Conclusion: The implementation of the Three I's for collaborative TB-HIV activities in pilot sites in Nepal was successful and should be scaled up.
Setting: The three government tertiary care hospitals providing care for people living with the human immunodeficiency virus (PLHIV) in Kathmandu, Nepal. Objectives: To assess 1) the screening cascades for intensified case finding for tuberculosis (TB), 2) isoniazid preventive therapy (IPT), including demographic and clinical factors associated with treatment interruption, and 3) TB infection control (IC) in the health facilities. Design: A cross-sectional study of new PLHIV enrolled from January 2012 to December 2014. Results: Among 572 registered PLHIV, 91% were on antiretroviral therapy. Of those registered, 561 (98%) were screened for TB and 73 (13%) were diagnosed with TB (17 [25%] sputum smear-positive, 17 [25%] smear-negative and 35 [51%] extra-pulmonary). Among the 488 (87%) PLHIV without active TB, 157 (32%) were initiated on IPT, of whom 136 (87%) completed treatment and 17 (11%) interrupted treatment. Those who experienced adverse events were 12 times more likely to interrupt IPT. TB IC showed gaps in personal control measures and supporting structures and policies. Conclusion: The implementation of the Three I's for collaborative TB-HIV activities in pilot sites in Nepal was successful and should be scaled up.
Entities:
Keywords:
Nepal; human immunodeficiency virus; infection control; intensified case finding; isoniazid preventive therapy; tuberculosis
Authors: Haileyesus Getahun; Reuben Granich; Delphine Sculier; Christian Gunneberg; Leopold Blanc; Paul Nunn; Mario Raviglione Journal: AIDS Date: 2010-11 Impact factor: 4.177
Authors: Alison D Grant; Kathryn T Mngadi; Clare L van Halsema; Mariëtha M Luttig; Katherine L Fielding; Gavin J Churchyard Journal: AIDS Date: 2010-11 Impact factor: 4.177
Authors: S Zaeh; R Kempker; E Stenehjem; H M Blumberg; O Temesgen; I Ofotokun; A Tenna Journal: Int J Tuberc Lung Dis Date: 2013-11 Impact factor: 2.373
Authors: Mahendra M Reddy; Pruthu Thekkur; Nagesh Ramya; Prasanna B T Kamath; Suresh G Shastri; Ravi B N Kumar; Palanivel Chinnakali; Abhay S Nirgude; Chethana Rangaraju; Narasimhaiah Somashekar; Ajay M V Kumar Journal: Glob Health Action Date: 2020 Impact factor: 2.640